Startups

MIP Diagnostics develops synthetic antibodies for use in diagnostic devices.

MIP Discovery develops synthetic affinity reagents for cell and gene therapies.

Macomics develops novel immuno-therapies to overcome resistance in cancer treatments.

Magnitude Biosciences provides nematode worm testing services to accelerate preclinical drug discovery for biotech firms.

Maxion Therapeutics develops antibody-based biologic drugs for ion channel and GPCR-driven diseases.

MediSieve develops magnetic blood filtration technology to treat blood-borne diseases.

Developing engineered stem-cell treatments for arthritis.

Metrion Biosciences provides specialist ion channel screening and drug discovery services.

MiAlgae develops biotechnology to create sustainable Omega 3 from industry coproducts.

MiNA Therapeutics develops small activating RNA medicines to restore normal cell function.